SP1 and cardiac hypertrophy: On the other hand, few reports have revealed the usefulness of specific Sp1 inhibitor(s) in the treatment of cardiac hypertrophy partly because Sp1 is a universally present molecule and partly because sequence-specific transcription factors are notorious to drug.